2,6-dihydroxy-3,4-dimethyl-benzoic acid | 647014-67-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2,6-dihydroxy-3,4-dimethyl-benzoic acid
• 英文别名: 2,6-Dihydroxy-3,4-dimethyl-benzoesaeure；2,6-Dihydroxy-3,4-dimethylbenzoic acid；2,6-dihydroxy-3,4-dimethylbenzoic acid
• CAS: 647014-67-3
• 化学式: C₉H₁₀O₄
• 分子量: 182.176
• InChiKey: AFDAGSBHAOWQFR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  77.8
• 氢给体数：
  3
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2,6-dihydroxy-3,4-dimethyl-benzoic acid 在 盐酸 、 乙醚 作用下， 生成 3-[(2,4-dinitro-phenylhydrazono)-methyl]-2,6-dihydroxy-4,5-dimethyl-benzoic acid methyl ester
  参考文献：
  名称：

  640. 4：5-二甲基间苯二酚的衍生物

  摘要：

  DOI：

  10.1039/jr9490003038
• 作为产物：
  描述：

  4,5-二甲基间苯二酚 、 methylammonium carbonate 在 potassium hydrogencarbonate 、 甘油 作用下， 生成 2,6-dihydroxy-3,4-dimethyl-benzoic acid
  参考文献：
  名称：

  640. 4：5-二甲基间苯二酚的衍生物

  摘要：

  DOI：

  10.1039/jr9490003038

文献信息

• RESIST COMPOSITION, METHOD OF FORMING RESIST PATTERN, AND COMPOUND
  申请人：TOKYO OHKA KOGYO CO., LTD.

  公开号：US20200183273A1

  公开（公告）日：2020-06-11

  A resist composition including a base material component (A) whose solubility in a developing solution is changed due to the action of an acid, and a compound (D0) formed of an anion moiety and a cation moiety which is represented by Formula (d0), in which the cation moiety of the compound (D0) has a Log P value of less than 7.7. In the formula, M m+ represents an m-valent organic cation, R d0 represents a substituent, p represents an integer of 0 to 3, q represents an integer of 0 to 3, n represents an integer of 2 or greater, and a relationship of “n+p≤(q×2)+5” is satisfied.

  一种抗蚀组合物，包括一种基材料组分（A），由于酸的作用而在显影液中溶解性发生改变，以及由阴离子基团和由公式（d0）表示的阳离子基团组成的化合物（D0）。其中，化合物（D0）的阳离子基团的Log P值小于7.7。在公式中，Mm+表示m价有机阳离子，Rd0表示取代基，p表示0到3之间的整数，q表示0到3之间的整数，n表示大于等于2的整数，并且满足“n+p≤（q×2）+5”的关系。
• Koller; Passler, Monatshefte fur Chemie, 1930, vol. 56, p. 212,231
  作者：Koller、Passler

  DOI：——

  日期：——
• BORONIC COMPOUND COMPLEXING REAGENTS AND HIGHLY STABLE COMPLEXES
  申请人：PROLINX, INC.

  公开号：EP0915832B1

  公开（公告）日：2002-10-02
• 22438, 23553, 25278, and 26212 novel human sulfatases
  申请人：Millennium Pharmaceuticals, Inc.

  公开号：US20030162279A1

  公开（公告）日：2003-08-28

  The present invention relates to newly identified human sulfatases. In particular, the invention relates to sulfatase polypeptides and polynucleotides, methods of detecting the sulfatase polypeptides and polynucleotides, and methods of diagnosing and treating sulfatase-related disorders. Also provided are vectors, host cells, and recombinant methods for making and using the novel molecules.
• Novel 27411, 23413, 22438, 23553, 25278, 26212, NARC SC1, NARC 10A, NARC 1, NARC 12, NARC 13, NARC17, NARC 25, NARC 3, NARC 4, NARC 7, NARC 8, NARC 11, NARC 14A, NARC 15, NARC 16, NARC 19, NARC 20, NARC 26, NARC 27, NARC 28, NARC 30, NARC 5, NARC 6, NARC 9, NARC 10C, NARC 8B, NARC 9, NARC2A, NARC 16B, NARC 1C, NARC1A, NARC 25, 86604 and 32222 molecules and uses therefor
  申请人：Millennium Pharmaceuticals, Inc.

  公开号：US20040009553A1

  公开（公告）日：2004-01-15

  The invention provides isolated nucleic acids molecules and proteins, designated 27411, 23413, 22438, 23553, 25278, 26212, NARC SC1, NARC 10A, NARC 1, NARC 12, NARC 13, NARC 17, NARC 25, NARC 3, NARC 4, NARC 7, NARC 8, NARC 11, NARC 14A, NARC 15, NARC 16, NARC 19, NARC 20, NARC 26, NARC 27, NARC 28, NARC 30, NARC 5, NARC 6, NARC 9, NARC 10C, NARC 8B, NARC 9, NARC2A, NARC 16B, NARC 1C, NARC 1A, NARC 25, 86604 and 32222 nucleic acid molecules and proteins. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing said nucleic acid molecules, host cells into which the expression vectors have been introduced, nonhuman transgenic animals in which a said genes have been introduced or disrupted, fusion proteins, antigenic peptides and antibodies to said proteins. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided.